ERBB3 and breast carcinoma: Moreover, our study reveals a significantly positive correlation between HER3 and PHF8 in TNBC specimens and clinic relevance of the HER3/miR-34b-5p/PHF8 axis in association with the survival outcomes of breast cancer patients.